Effect of Delivered Dosage of Cigarette Smoke Toxins on the Levels of Urinary Biomarkers of Exposure

Urinary metabolites of tobacco smoke toxins are often used as biomarkers for the evaluation of active and passive exposure to cigarette smoke toxins. In a study of healthy smokers, we investigated concentrations of urinary biomarkers in relation to concentrations of selected toxins in mainstream cigarette smoke as determined by machine smoking of cigarettes in a manner that mimics an individual's smoking behavior (topography). Concentrations of nicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and benzo(a)pyrene, in mainstream smoke determined under human smoking conditions, and their urinary metabolites cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and 1-hydroxypyrene were established for 257 individuals who smoked low-yield (0.1-0.8 mg Federal Trade Commission nicotine/cigarette; mean, 0.66; n = 87), medium-yield (0.9-1.2 mg nicotine/cigarette; mean, 1.1; n = 109), and high-yield cigarettes (nicotine, >1.3 mg nicotine/cigarette; mean, 1.41; n = 61). Levels of urinary metabolites expressed per unit of delivered parent compounds decreased with increased smoke emissions. In smokers of low-, medium-, and high-yield cigarettes, the respective cotinine (ng/mg creatinine)-to-nicotine (mg/d) ratios were 89.4, 77.8, and 57.1 (low versus high; P = 0.06); the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (pmol/mg creatinine)-to-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (ng/d) ratios were 0.81, 0.55, and 0.57 (low versus high; P = 0.05); and the 1-hydroxypyrene (pg/mg creatinine)-to-benzo(a)pyrene (ng/d) ratios were 1.55, 1.13, and 0.97 (low versus high; P = 0.008). Similarly, means of cotinine per unit of delivered nicotine in smokers who consumed <20 cigarettes per day was 3.5-fold higher than in those who smoked >20 cigarettes per day. Likewise, a negative correlation was observed between cotinine-to-nicotine ratios and delivered doses of nicotine in subgroups of smokers who used the identical brand of cigarette, namely a filter tip-vented Marlboro (r = −0.59), which is a popular brand among Euro-Americans, and Newport (r = −0.37), a menthol-flavored cigarette without filter tip vents that is preferred by African-Americans. Thus, the intensity of the exposures significantly affects the levels of urinary biomarkers of exposure and should be taken into account in the evaluation of human exposure to cigarette smoke toxins. (Cancer Epidemiol Biomarkers Prev 2007;16(7):1408–15)

[1]  J. Muscat,et al.  Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[2]  Neil E. Caporaso,et al.  Cigarette Smoking and Lung Cancer: Modeling Total Exposure and Intensity , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  R. Kinser,et al.  Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  S. Feng,et al.  Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[5]  J. Muscat,et al.  Racial differences in exposure and glucuronidation of the tobacco‐specific carcinogen 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) , 2005, Cancer.

[6]  D. Hatsukami,et al.  Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[7]  N. Dastugue,et al.  Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): Results from Cancer and Leukemia Group B study 8461 and review of the literature , 2004, Cancer.

[8]  M. Thun,et al.  Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8 , 2004, BMJ : British Medical Journal.

[9]  D. Christiani,et al.  Exposure to Environmental Tobacco Smoke and Urinary 1‐Hydroxypyrene Levels in Preschool Children , 2003, The Kaohsiung journal of medical sciences.

[10]  R. Shore,et al.  Personal exposure to different levels of benzene and its relationships to the urinary metabolites S-phenylmercapturic acid and trans,trans-muconic acid. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  P. Shields Tobacco smoking, harm reduction, and biomarkers. , 2002, Journal of the National Cancer Institute.

[12]  M. Hubbard,et al.  Proteomic analysis of dental tissues. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  L. Kozlowski,et al.  Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents , 2002, Tobacco control.

[14]  M. Kogevinas,et al.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. , 2000, Mutation research.

[15]  N. Benowitz,et al.  Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism , 2000, Clinical pharmacology and therapeutics.

[16]  D. Christiani,et al.  Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9, 10-tetrahydrobenzo[a]pyrene in human urine by gas chromatography/negative ion chemical ionization/mass spectrometry. , 2000, Chemical research in toxicology.

[17]  S. Stellman,et al.  Doses of nicotine and lung carcinogens delivered to cigarette smokers. , 2000, Journal of the National Cancer Institute.

[18]  D Hoffmann,et al.  Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. , 1999, Cancer letters.

[19]  P. Strickland,et al.  Comparison of three analytical methods for 1-hydroxypyrene glucuronide in urine after non-occupational exposure to polycyclic aromatic hydrocarbons. , 1999, Toxicology letters.

[20]  M. Djordjevic,et al.  Nicotine regulates smoking patterns. , 1997, Preventive medicine.

[21]  F. Jongeneelen Methods for routine biological monitoring of carcinogenic PAH-mixtures. , 1997, The Science of the total environment.

[22]  R. Singh,et al.  A rapid and simple method for the analysis of 1-hydroxypyrene glucuronide: a potential biomarker for polycyclic aromatic hydrocarbon exposure. , 1995, Carcinogenesis.

[23]  M. Djordjevic,et al.  Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. , 1995, Carcinogenesis.

[24]  S. Hecht,et al.  Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. , 1993, Cancer research.

[25]  Rico Nil,et al.  Nicotine yield as determinant of smoke exposure indicators and puffing behavior , 1991, Pharmacology Biochemistry and Behavior.

[26]  Nancy J. Haley,et al.  Puffing topography as a determinant of smoke exposure , 1990, Pharmacology Biochemistry and Behavior.

[27]  N. Benowitz,et al.  Influence of tobacco abstinence on the disposition kinetics and effects of nicotine , 1987, Clinical pharmacology and therapeutics.

[28]  E. Wynder,et al.  Comparative epidemiology of tobacco-related cancers. , 1977, Cancer research.

[29]  L. Tanoue Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer , 2007 .

[30]  Paolo Vineis,et al.  Dose‐response relationship in tobacco‐related cancers of bladder and lung: A biochemical interpretation , 2004, International journal of cancer.

[31]  Office on Smoking The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[32]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[33]  R. Tyndale,et al.  Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration. , 2003, Molecular pharmacology.

[34]  S. Hecht,et al.  Determination of Hemoglobin and Serum Albumin Adducts of Benzo[a]Pyrene by Gas Chromatography-Mass Spectrometry in Humans and Their Relation to Exposure and to other Biological Markers , 1999 .

[35]  M. Law,et al.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. , 1997, British Journal of Cancer.

[36]  D. Hoffmann,et al.  Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. , 1991, Critical reviews in toxicology.